Bridgewater Chapter Upcoming Events Join PCCI

CD Diagnostics

Research & development company

Presenter: Michael Behr, President & COO of CD Diagnostics


Tuesday, January 18, 2011

Embassy Suites, Chesterbrook, Pennsylvania (directions)



CD Diagnostics is developing a diagnostic test that uses biomarkers in synovial fluid to indicate the presence of infection in total joint replacements. This diagnostic test focuses on the body's biological response to infection rather than the infection itself. A major advantage of this test is that the test is specific and local to the joint replacement. By measuring the presence of protein biomarkers in the synovial (joint) fluid around the total joint replacement, this diagnostic test eliminates the potential for false positive or negative results that can occur with general tests that use existing technology. CD Diagnostics conducted three studies that verify the accuracy and specificity of this technology. The diagnostic test being developed by CD Diagnostics will be more accurate, take less time, save money and establish a clearer picture for a patient's treatment pathway than existing technology.



3 Major Issues


  1. CD Diagnostics has a solid technology with a strong patent that might increase in scope with a patent continuance that looks promising. Is it a better idea for CD Diagnostics to put all of it's energy into developing one product and selling the company, with it's technology, to a potential buyer or would it be better to develop an extended line of applications for this technology and then approach a potential buyer/partner?

  2. CD Diagnostics has been approached by a couple of large companies that might be interested in a strategic partnership. Is a strategic partnership a good idea at this point for CD Diagnostics? What models for a strategic partnership would make sense?

  3. CD Diagnostics is looking at models for pricing of Cygnasure®. What models exist to determine an appropriate price for a product like Cygnasure®? How should we begin to determine a price for Cygnasure®.






6:30 - Cocktails & Dinner (Cash bar and special 2-entree buffet menu)

8:00 -Michael Behr, President & COO of CD Diagnostics, will deliver the Company's "Elevator" Pitch to the Group

8:20 - A Panel will address 3 Major Issues for the Company

9:00 - Open discussion: members and guests



<Top of the page>



Available Media

Please note: All information obtained here is the property of those presenting and should not be copied or duplicated without written consent.



CD Diagnostics Presentation


None available at this time


None available at this time


01/18/2011 - CD Diagnostics Webcast

Presenters Contact Info:






Questions or Coments?

Contact: Peter van der Kam, | (610) 296-8086




Good Company! Good Drink! Good Food! Good Program! Good Fun!


Site Navigation



Pharmaceutical Consulting Consortium International, Inc., or (610) 296-8086

Meetings Held at Embassy Suites - Valley Forge

888 Chesterbrook Blvd, Chesterbrook, Pennsylvania 19087

All content on this website is copyrighted and should not be reproduced without the consent of PCCI.

© Copyright 2016-2018



Tat Communication Inc